BIOADAPTIVES, INC.
BDPTdata completeness 88%10 fiscal years on fileData notes: no data for concept 'totalDebt'
i. The business — what you’d actually own
| Figure | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | $19,7761 | $17,1762 | $28,5653 | $12,6694 | $18,2784 |
| Net income | −$1.05M5 | −$895,5706 | −$712,4667 | −$899,1618 | −$1.56M8 |
| Operating cash flow | −$158,6519 | −$227,25910 | −$223,77311 | −$249,51712 | −$516,02512 |
| Capital expenditure | — | — | — | $013 | $18,00013 |
| Free cash flow (derived) | — | — | — | −$249,51712 | −$534,02512 |
| Total debt | — | — | — | — | — |
| Cash & equivalents | $82,93614 | $82,93615 | $88,55716 | $261,88517 | $215,20517 |
| Diluted shares | 50.8M | 252.6M | 6.0M | 8.2M | 10.1M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
ii. Your slice — ownership made literal
If you owned
shares
Net assets behind them
−$2.11
your share of equity
Profit it earned you last year
−$1.55
Free cash flow it threw off
−$0.53
Debt you’d be carrying
—
10 shares is a claim on −$2.11 of net worth that earned you −$1.55 and generated −$0.53 of cash last year.
iii. Is this a good business?
Moat signal · return on equity
— avg · 5y
Not enough data in the filings for a return-on-capital reading.
seeing a moat in the numbers →Management signal · capital allocation
−80% shares · 5y
Share count is down 80% over 5 years — management has been buying back stock, quietly handing owners a bigger slice.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
iv. What it’s worth — engine v0.1.0
DCF · Growth Exit 10Y
not applicable
only 2 years of FCF (need ≥3) — model not applicable
DCF · Growth Exit 5Y
not applicable
only 2 years of FCF (need ≥3) — model not applicable
Earnings Power Value
not applicable
normalized (5y-median) earnings non-positive — EPV undefined
Graham Number
not applicable
diluted EPS missing or non-positive — Graham Number undefined
Different models answer different questions — which to trust when →
Sources — the receipts
- 10-K · period ending 2021-12-31 · accession 0001640334-23-000532 (Revenues)
- 10-K · period ending 2022-12-31 · accession 0001640334-24-000602 (Revenues)
- 10-K · period ending 2023-12-31 · accession 0001640334-25-000660 (Revenues)
- 10-K · period ending 2024-12-31 · accession 0001640334-26-000718 (Revenues)
- 10-K · period ending 2021-12-31 · accession 0001640334-23-000532 (NetIncomeLoss)
- 10-K · period ending 2022-12-31 · accession 0001640334-24-000602 (NetIncomeLoss)
- 10-K · period ending 2023-12-31 · accession 0001640334-25-000660 (NetIncomeLoss)
- 10-K · period ending 2024-12-31 · accession 0001640334-26-000718 (NetIncomeLoss)
- 10-K · period ending 2021-12-31 · accession 0001640334-23-000532 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-12-31 · accession 0001640334-24-000602 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-12-31 · accession 0001640334-25-000660 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2024-12-31 · accession 0001640334-26-000718 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2024-12-31 · accession 0001640334-26-000718 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2021-12-31 · accession 0001640334-23-000532 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2022-12-31 · accession 0001640334-24-000602 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-12-31 · accession 0001640334-25-000660 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-12-31 · accession 0001640334-26-000718 (CashAndCashEquivalentsAtCarryingValue)